Thrombopoietin-induced signal transduction and potentiation of platelet activation

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 377-384

  Oda, Atsushi ^a,c   Miyakawa, Yoshitaka ^a   Druker, Brian J ^d   Ozaki, Katsutoshi ^a   Ohashi, Hideya ^b   Kato, Takashi ^b   Miyazaki, Hiroshi ^b   Handa, Makoto ^d   Ikebuchi, Kenji ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; RECEPTOR; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; GENE SEQUENCE; GENE STRUCTURE; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTHEMIA; THROMBOCYTOPENIA;

EID: 0032695763     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615856     Document Type: Conference Paper

References (68)

1. Kelemen E. Specific thrombopoietin cloned and sequenced -with personal retrospect and clinical prospects. Leukemia. 1995;9:1-2.
2. Skoda RC, Seldin DC, Chiang MK, Peichel CL, Vogt TF, Leder. Murine c-mpl: A member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 1993;12:2645-2653.
3. Methia N, Louache F, Vainchenker W, Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 1993;82:1395-1401.
4. Kaushansky K. Thrombopoietin. N Engl J Med. 1998;339:746-754.
5. Kuter DJ. Thrombopoietins and thrombopoiesis: A clinical perspective. Vox Sang. 1998;74(Suppl 2):75-85.
6. Kato T, Matsumoto A, Ogami K, Tahara T, Morita H, Miyazaki H. Native thrombopoietin: Structure and function. Stem Cells. 1998;16:322-328.
7. Wendling F, Vainchenker W. Thrombopoietin and its receptor. Eur Cytokine Netw. 1998;9:221-231.
8. Souyri M. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin. Semin Hematol. 1998;35:222-231.
9. Ku H, Hirayama F, Kato T, Miyazaki H, Aritomi M, Ota Y, D'Andrea AD, Lyman SD, Ogawa M. Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2. Blood. 1996;88:4124-4131.
10. Taksin AL, Couedic JPL, Dusanter-Fourt I, Masse A, Giraudier S, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N. Autonomous megakaryocyte growth in essential thrombo-cythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L. Blood. 1999;93:125-139.
11. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995;92:3234-3238.
12. Kitamura T, Onishi M, Yahata T, Kanakura Y, Asano S. Activating mutations of the transmembrane domain of MPL in vitro and in vivo: incorrect sequence of MPL-K, an alternative spliced form of MPL. Blood. 1998;92:2596-2597.
13. Brizzi MF, Battaglia E, Rosso A, Strippoli P, Montrucchio G, Camussi G, Pegoraro L. Regulation of polymorphonuclear cell activation by thrombopoietin. J Clin Invest. 1997;99:1576-1584.
14. Kato T, Oda A, Inagaki Y, Ohashi H, Matsumoto A, Ozaki K, Miyakawa Y, Watarai H, Fuju K, Kokubo A, Kadoya T, Ikeda Y, Miyazaki H. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA. 1997;94:4669-4674.
15. Hokom MM, Lacey D, Kinstler OB, Choi E, Kaufman S, Faust J, Rowan C, Dwyer E, Nichol JL, Grasel T. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood. 1995;86:4486-4592.
16. Oda A, Ozaki K, Druker BJ, Miyakawa Y, Miyazaki H, Handa M, Morita H, Ohashi H, Ikeda Y. P120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin. Blood. 1996;88:1330-1338.
17. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC, Barrett RW, Dower WJ. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science. 1997;276:1696-1699.
18. Lalau Keraly C, Kinlough-Rathbone RL, Packham MA, Suzuki H, Mustard JF. Conditions affecting the responses of human platelets to epinephrine. Thromb Haemost. 1988;60:209-216.
19. Oda A, Miyakawa Y, Druker BJ, Ozaki K, Yabusaki K, Shirasawa Y, Handa M, Kato T, Miyazaki H, Shimosaka A, Ikeda Y. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood. 1996;87:4664-4670.
20. Ezumi Y, Takayama H, Okuma M. Thrombopoietin, c-mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Letts. 1995;374:48-52.
21. Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood. 1996;87:439-446.
22. Livnah O, Stura EA, Middleton SA, Johson DL, Jolliffe LK, Wilson IA. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 1999;283:987-990.
23. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW . Thrombocytopenia in c-mpl-deficient mice. Science. 1994;265:1445-1457.
24. de Sauvage FJ, Carver-Moore K, Luoh SM, Ryan A, Dowd M, Eaton DL, Moore MW. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996;183:651-656.
25. Gainsford T, Roberts AW, Kimura S, Metcalf D, Dranoff G, Mulligan RC, Begley CG, Robb L, Alexander WS. Cytokine production and function in c-mpl-deficient mice: No physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Blood. 1998;91:2745-2752.
26. Muraoka K, Ishii E, Tsuji K, Yamamoto S, Yamaguchi H, Hara T, Koga H, Nakahata T, Miyazaki S. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia. Br J Haematol. 1997;96:287-292.
27. Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, Good RA, Hara T. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci USA. 1999;96:3132-3136.
28. Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet. 1998;18:49-52.
29. Kondo T, Okabe M, Sanada M, Kurosawa M, Suzuki S, Kobayashi M, Hosokawa M, Asaka M. Familial essential thrombocythemia associated with one-base deletion in the 5'-untranslated region of the thrombopoietin gene. Blood. 1998;92:1091-1096.
30. Komura-Naito E, Matsumura T, Sawada T, Kato T, Tahara T. Thrombopoietin in patients with hepatoblastoma. Blood. 1997;90:2849-2850.
31. Yamaguchi H, Ishii E, Hayashida Y, Hirata Y, Sakai R, Miyazaki S. Mechanism of thrombocytosis in hepatoblastoma: A case report. Pediatr Hematol Oncol. 1996;13:539-544.
32. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998;93:385-395.
33. Drachman JG, Kaushansky K. Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci USA. 1997;94:2350-2355.
34. Morita H, Tahara T, Matsumoto A, Kato T, Miyazaki H, Ohashi H. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Letts. 1996;395:228-234.
35. Rouyez MC, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol. 1997;17:4991-5000.
36. Hill RJ, Zozulya S, Lu YL, Hollenbach PW, Joyce-Shaikh B, Bogenberger J, Gishizky ML. Differentiation induced by the c-mpl cytokine receptor is blocked by mutant Shc adaptor protein. Cell Growth Differ. 1996;7:1125-1134.
37. Zauli G, Gibellini D, Vitale M, Secchiero P, Celeghini C, Bassini A, Pierpaoli S, Marchisio M, Guidotti L, Capitani S. The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. Blood. 1998;92:472-480.
38. Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ. Distinct regions of c-mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and She phosphorylation. Proc Natl Acad Sci USA. 1995;92:5292-5296.
39. Takatoku M, Kametaka M, Shimizu R, Miura Y, Komatsu N. Identification of functional domains of the human thrombopoietin receptor required for growth and differentiation of megakaryocytic cells. J Biol Chem. 1997;272:7259-7263.
40. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J. Regulation of platelet activation in vitro by the c-mpl ligand, thrombopoietin. Blood. 1995;86:4054-4062.
41. Rodriguez-Linares B, Watson SP. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J. 1996;316:93-98.
42. Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T, Abe T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 1995;74:1541-1545.
43. Montrucchio G, Brizzi MF, Calosso G, Marengo S, Pegoraro L, Camussi G. Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood. 1996;87:2762-2768.
44. Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and She in human blood platelets. Blood. 1995;86:23-27.
45. Oda A, Miyakawa Y, Druker BJ, Ishida A, Ozaki K, Ohashi H, Wakui M, Handa M, Watanabe K, Okamoto S, Ikeda Y. Crkl is constitutively tyrosine-phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood. 1996;88:4304-4313.
46. Miyakawa Y, Oda A, Druker BJ, Ozaki K, Handa M, Ohashi H, Ikeda Y. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Blood. 1997;89:2789-2798.
47. Ozaki K, Oda A, Wakao H, Rhodes J, Druker BJ, Ishida A, Wakui M, Okamoto S, Morita K, Handa M, Komatsu N, Ohashi H, Miyajima A, Ikeda Y. Thrombopoietin induces association of crkl with STAT5 but not STAT3 in human platelets. Blood. 1998;92:4652-4662.
48. Oda A, Sawada K, Druker BJ, Ozaki K, Takano H, Koizumi K, Fukada Y, Handa M, Koike T, Ikeda Y. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood. 1998;92:443-451.
49. Rhodes J, York RD, Tajinda K, Tara D, Druker BJ. Analysis of Crkl and STAT5 interaction in BCR-ABL expressing cells. Blood. 1998;92(Suppl 1):476a.
50. Ballmaier M, Schulze H, Strauss G, Cherkaoui K, Wittner N, Lynen S, Wolters S, Bogenberger J, Weite K. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood. 1997;90:612-619.
51. Strippoli P, Savoia A, Iolascon A, Tonelli R, Savino M, Giordano P, D'Avanzo M, Massolo F, Locatelli F, Borgna C, De Mattia D, Zelante L, Paolucci G, Bagnara GP. Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii. Br J Haematol. 1998;103:311-314.
52. Sekine I, Hagiwara T, Miyazaki H, Hirayama K, Dobashi H, Kogawa K, Yoshioka S. Thrombocytopenia with absent radii syndrome: Studies on serum thrombopoietin levels and megakaryopoiesis in vitro. J Pediatr Hematol Oncol 1998;20:74-78.
53. Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood. 1997;90:4031-4038.
54. Li J, Xia Y, Kuter DJ. Analysis of the thrombopoietin receptor (MPL) on patients from normal and essential thrombocythemic (ET) patients. Blood. 1996;88:545a.
55. Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med. 1998;338:572-580.
56. Drachman JG, Sabath DF, Fox NE, Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 1997;89:483-492.
57. Ziegler S, de Sauvage FJ, Skoda RC. Transgenic rescue of the mpl knockout with mpl tyrosine mutants. Blood. 1998;92(Suppl 1):713a.
58. de Sauvage FJ, Lipari T, Steinmetz H, Blunting S, Jackson CW, Luoh S-M. Activation of the MAPK pathway is not required for platelet production in vivo. Blood. 1998;92(Suppl 1):713a.
59. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797-819.
60. Stoffel R, Ziegler S, Ghilardi N, Ledermann B, de Sauvage FJ, Skoda RC. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo. Proc Natl Acad Sci USA. 1999;96:698-702.
61. Cantrell D. The real LAT steps forward. Trends Cell Biol. 1998;8:180-182.
62. Gibbins JM, Briddon S, Shutes A, van Vugt MJ, van de Winkel JGJ, Saito T, Watson SP. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activator of T cells (LAT) in platelets stimulated by collagen and convulxin. J Biol Chem. 1998;273:34437-34443.
63. Saci A, Pain S, Rendu F, Bachelot-Loza C. Fc receptor-mediated platelet activation is dependent on phosphatidylinositol 3-kinase activation and involves p120(Cbl). J Biol Chem. 1999;274:1898-1904.
64. Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vavl. Curr Biol. 1998;8:1289-1299.
65. Sarkar S. Tyrosine phosphorylation and translocation of LAT in platelets. FEBS Lett. 1998;441:357-360.
66. Duprez V, Blank U, Chretien S, Gisselbrecht S, Mayeux P. Physical and functional interaction between p72(syk) and erythropoietin receptor. J Biol Chem. 1998;273:33985-33990.
67. Rittenhouse SE. Phosphoinositide 3-kinase activation and platelet function. Blood. 1996;88(12):4401-4414.
68. O'Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood. 1996;88:3288-3298.